Abstract 13816: Dantrolene Enhances Binding of Calmodulin to RyR2 in CPVT Which Mutation Located at Central Domain but Does Not Enhance That in CPVT With Mutation at CaM-like Domain
IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF ha...
Saved in:
Published in: | Circulation (New York, N.Y.) Vol. 132; no. Suppl_3 Suppl 3; p. A13816 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
by the American College of Cardiology Foundation and the American Heart Association, Inc
10-11-2015
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF hand motifs and are called calmodulin (CaM)-like domain (CaMLD). Some of the human CPVT mutations were reported in this CaMLD. In this study we investigated the molecular mechanism of arrhythmogenesis of CPVT with mutation at CaMLD comparing R2474S and N4103K KI mice.Methods and ResultsVT and/or Vf were frequently observed after caffeine plus epinephrine infusion in KI mice (R2474S100%, N4103K43%), but not in WT mice. CaM binding affinity to RyR2 was assessed by incorporation of exogenous CaM labeled with HiLyte Fluor® in isolated saponin-permeabilized cardiomyocytes. The CaM binding affinity was decreased in both R2474S-KI (Kd400 nM) and N4103K-KI cells (Kd165 nM) compared with WT cells (Kd90 nM) in the presence of cAMP. Addition of 1 μM dantrolene (DAN), the zipper of N-terminal and central domain of RyR2, increased the affinity of CaM to RyR2 in R2474S-KI cells, but did not increase that in N4103K-KI cells. Frequency of the Ca sparks (SpF) was measured in isolated saponin-permeabilized cardiomyocytes. SpF was much higher in KI cells than in WT cells (R2474S-KI17.2±6.7, N4103K-KI21.5±6.3, WT10.6±4.1). Addition of 1 μM DAN to R2474S-KI cells significantly decreases SpF (10.4±5.5), however, DAN did not decrease SpF in N4103K-KI (21.8±6.9). Spontaneous Ca transient (SCaT) was measured during sequential pacing from 1 to 5 Hz in isolated intact cardiomyocytes. The SCaT was rarely observed in WT cells even with 10 nM isoproterenol, whereas that was observed in 37 % of R2474S-KI and in 33 % of N4103K-KI cells. Addition of DAN to KI cells, decrease frequency of SCaT in R2474S-KI (13 %), however, did not decrease in N4103-KI cells (30 %).ConclusionsIn CPVT with central domain mutation, domain zipper is effective to inhibit arrhythmias. In CaMLD mutation, structural abnormality might be in the downstream of the N-terminal and central domain switch, so that the DAN is not effective. CaMLD might be a novel therapeutic target of lethal arrhythmias. |
---|---|
AbstractList | IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF hand motifs and are called calmodulin (CaM)-like domain (CaMLD). Some of the human CPVT mutations were reported in this CaMLD. In this study we investigated the molecular mechanism of arrhythmogenesis of CPVT with mutation at CaMLD comparing R2474S and N4103K KI mice.Methods and ResultsVT and/or Vf were frequently observed after caffeine plus epinephrine infusion in KI mice (R2474S100%, N4103K43%), but not in WT mice. CaM binding affinity to RyR2 was assessed by incorporation of exogenous CaM labeled with HiLyte Fluor® in isolated saponin-permeabilized cardiomyocytes. The CaM binding affinity was decreased in both R2474S-KI (Kd400 nM) and N4103K-KI cells (Kd165 nM) compared with WT cells (Kd90 nM) in the presence of cAMP. Addition of 1 μM dantrolene (DAN), the zipper of N-terminal and central domain of RyR2, increased the affinity of CaM to RyR2 in R2474S-KI cells, but did not increase that in N4103K-KI cells. Frequency of the Ca sparks (SpF) was measured in isolated saponin-permeabilized cardiomyocytes. SpF was much higher in KI cells than in WT cells (R2474S-KI17.2±6.7, N4103K-KI21.5±6.3, WT10.6±4.1). Addition of 1 μM DAN to R2474S-KI cells significantly decreases SpF (10.4±5.5), however, DAN did not decrease SpF in N4103K-KI (21.8±6.9). Spontaneous Ca transient (SCaT) was measured during sequential pacing from 1 to 5 Hz in isolated intact cardiomyocytes. The SCaT was rarely observed in WT cells even with 10 nM isoproterenol, whereas that was observed in 37 % of R2474S-KI and in 33 % of N4103K-KI cells. Addition of DAN to KI cells, decrease frequency of SCaT in R2474S-KI (13 %), however, did not decrease in N4103-KI cells (30 %).ConclusionsIn CPVT with central domain mutation, domain zipper is effective to inhibit arrhythmias. In CaMLD mutation, structural abnormality might be in the downstream of the N-terminal and central domain switch, so that the DAN is not effective. CaMLD might be a novel therapeutic target of lethal arrhythmias. Abstract only Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF hand motifs and are called calmodulin (CaM)-like domain (CaMLD). Some of the human CPVT mutations were reported in this CaMLD. In this study we investigated the molecular mechanism of arrhythmogenesis of CPVT with mutation at CaMLD comparing R2474S and N4103K KI mice. Methods and Results: VT and/or Vf were frequently observed after caffeine plus epinephrine infusion in KI mice (R2474S: 100%, N4103K: 43%), but not in WT mice. CaM binding affinity to RyR2 was assessed by incorporation of exogenous CaM labeled with HiLyte Fluor® in isolated saponin-permeabilized cardiomyocytes. The CaM binding affinity was decreased in both R2474S-KI (Kd: 400 nM) and N4103K-KI cells (Kd: 165 nM) compared with WT cells (Kd: 90 nM) in the presence of cAMP. Addition of 1 μM dantrolene (DAN), the zipper of N-terminal and central domain of RyR2, increased the affinity of CaM to RyR2 in R2474S-KI cells, but did not increase that in N4103K-KI cells. Frequency of the Ca 2+ sparks (SpF) was measured in isolated saponin-permeabilized cardiomyocytes. SpF was much higher in KI cells than in WT cells (R2474S-KI: 17.2±6.7, N4103K-KI: 21.5±6.3, WT: 10.6±4.1). Addition of 1 μM DAN to R2474S-KI cells significantly decreases SpF (10.4±5.5), however, DAN did not decrease SpF in N4103K-KI (21.8±6.9). Spontaneous Ca 2+ transient (SCaT) was measured during sequential pacing from 1 to 5 Hz in isolated intact cardiomyocytes. The SCaT was rarely observed in WT cells even with 10 nM isoproterenol, whereas that was observed in 37 % of R2474S-KI and in 33 % of N4103K-KI cells. Addition of DAN to KI cells, decrease frequency of SCaT in R2474S-KI (13 %), however, did not decrease in N4103-KI cells (30 %). Conclusions: In CPVT with central domain mutation, domain zipper is effective to inhibit arrhythmias. In CaMLD mutation, structural abnormality might be in the downstream of the N-terminal and central domain switch, so that the DAN is not effective. CaMLD might be a novel therapeutic target of lethal arrhythmias. |
Author | Yamamoto, Takeshi Ono, Makoto Oda, Tetsuro Fukui, Go Maeda, Takako Okuda, Shinichi Hino, Akihiro Kobayashi, Shigeki Nishimura, Shigehiko Suetomi, Takeshi Mochizuki, Mamoru Yano, Masafumi |
AuthorAffiliation | 1Dept of Medicine and Clinical Science, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan 2Div of Cardiology, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan |
AuthorAffiliation_xml | – name: 1Dept of Medicine and Clinical Science, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan 2Div of Cardiology, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan |
Author_xml | – sequence: 1 givenname: Shigehiko surname: Nishimura fullname: Nishimura, Shigehiko organization: 1Dept of Medicine and Clinical Science, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan 2Div of Cardiology, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan – sequence: 2 givenname: Takeshi surname: Yamamoto fullname: Yamamoto, Takeshi – sequence: 3 givenname: Go surname: Fukui fullname: Fukui, Go – sequence: 4 givenname: Takako surname: Maeda fullname: Maeda, Takako – sequence: 5 givenname: Akihiro surname: Hino fullname: Hino, Akihiro – sequence: 6 givenname: Takeshi surname: Suetomi fullname: Suetomi, Takeshi – sequence: 7 givenname: Makoto surname: Ono fullname: Ono, Makoto – sequence: 8 givenname: Mamoru surname: Mochizuki fullname: Mochizuki, Mamoru – sequence: 9 givenname: Tetsuro surname: Oda fullname: Oda, Tetsuro – sequence: 10 givenname: Shinichi surname: Okuda fullname: Okuda, Shinichi – sequence: 11 givenname: Shigeki surname: Kobayashi fullname: Kobayashi, Shigeki – sequence: 12 givenname: Masafumi surname: Yano fullname: Yano, Masafumi |
BookMark | eNpNkN1O3DAQRi1EpS60r1D5BbL4J4k3vYNAS6WFVnTVXlpjxyEuXntlO0I8GO9XL2wrruYbab4z0jlBxz54g9AnSpaUtvRM26iXlLNlmnc7J3nJK9oeoQVtWF3VDe-O0YIQ0lWCM_YenaT0p6wtF80CPZ-rlCPojF9an_El-ByDM97gKz-B1ybhC-sH6-9xGHEPbhuG2VmPc8B3T3cMl9j_-LXBvyerJ3wzZ8g2eLwOGrIZMGTcm8IEhy_DFsq1mnOJhXsb8r8neDOVw_8om9-Q9gS4qZx9MAfEB_RuBJfMx8M8RT-_XG3662r9_eu3_nxd6Y41ldJM1LpuBtK20CkQQqxGJYzSahCMkUGreqxXdTuScTCUmo4BVyOsBiW4ovwUta9UHUNK0YxyF-0W4pOkRO7Vy716WdTLg3r5IrEU69fiY3DZxPTg5kcT5WTA5UkW94QTKipGaEMpJbwiZTT8L9emjSw |
ContentType | Journal Article |
Copyright | 2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. |
Copyright_xml | – notice: 2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. |
DBID | AAYXX CITATION |
DOI | 10.1161/circ.132.suppl_3.13816 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1524-4539 |
EndPage | A13816 |
ExternalDocumentID | 10_1161_circ_132_suppl_3_13816 00003017-201511103-01115 |
GroupedDBID | - .XZ .Z2 01R 0R 1AW 1J1 29B 2WC 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O 7O~ 8RP AAAXR AAMOA AAMTA AAPBV AARTV AAWTL AAXQO ABBUW ABFLS ABOCM ABPMR ABPTK ABUFD ABXVJ ABZAD ACDDN ACEWG ACGFS ACRKK ACWDW ACWRI ACXNZ ADBBV ADCYY AE3 AENEX AFCHL AFUWQ AHMBA AHULI AHVBC AIJEX AJIOK ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII ASPBG AVWKF AWKKM AZFZN BAWUL BOYCO BQLVK BYPQX C45 CS3 DIK DU5 E3Z EBS EJD EX3 F2K F2L F2M F2N F5P GX1 H0 H0~ H1 H13 HZ IKYAY IN IN~ JF9 JG8 JK3 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O0- O9- OAG OAH OBH OCB ODA OGEVE OHASI OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWW OWY OXXIT P2P PQEST PQQKQ RAH RHF RIG RLZ RSW S4R S4S UPT V2I W2D WH7 WOQ WOW X3V X3W XZ YZZ Z2 ZA5 ZY1 ~H1 --- .-D .3C 0R~ 0ZK 18M 2FS 354 6PF AAAAV AAGIX AAHPQ AAIQE AAJCS AAQKA AASCR AASOK AASXQ AAUEB AAYXX ABASU ABDIG ABJNI ABQRW ABVCZ ACCJW ACGFO ACILI ACLDA ACOAL ACXJB ADGGA ADHPY AE6 AEBDS AEETU AFDTB AFEXH AFSOK AGINI AHOMT AHQNM AHRYX AINUH AJNWD AJZMW AKULP ALMTX AMKUR AMNEI AOHHW AYCSE CITATION DIWNM EEVPB ERAAH FCALG GNXGY GQDEL HLJTE HZ~ IKREB IPNFZ K-A K-F ODMTH OHH OHYEH OJAPA OLB OWBYB OWU OWV OWX OWZ T8P TEORI TR2 TSPGW VVN W3M W8F XXN XYM YFH YOC YSK YYM ZFV ZZMQN |
ID | FETCH-LOGICAL-c925-bc274c45d066a9ba7778fb7ebcbd7220dcb4f4846f0fde11e92a3bfa8db73b13 |
ISSN | 0009-7322 |
IngestDate | Thu Nov 21 23:07:48 EST 2024 Thu Aug 13 19:45:49 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl_3 Suppl 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c925-bc274c45d066a9ba7778fb7ebcbd7220dcb4f4846f0fde11e92a3bfa8db73b13 |
ParticipantIDs | crossref_primary_10_1161_circ_132_suppl_3_13816 wolterskluwer_health_00003017-201511103-01115 |
ProviderPackageCode | OVOZU L-C C45 7O~ AARTV ABPMR OLH ASCII BYPQX OLG AAMOA ODA ABZAD ABBUW JK3 H0~ 1J1 OLV OLU JG8 OLW OLZ OLY F2K F2M F2L F2N OHASI AHVBC KMI OGEVE K8S OVLEI AJIOK OPUJH V2I .XZ S4R S4S 4Q1 OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI ACEWG .Z2 N~7 IKYAY OVIDH AWKKM 40H N~B OBH X3V X3W ACDDN ACWRI BOYCO AIJEX AAXQO ~H1 AAMTA AAAXR OWW OCB OWY 01R ACXNZ OL1 AFCHL ABXVJ IN~ KD2 OXXIT 77Y ACWDW JF9 |
PublicationCentury | 2000 |
PublicationDate | 2015-November-10 2015-11-10 |
PublicationDateYYYYMMDD | 2015-11-10 |
PublicationDate_xml | – month: 11 year: 2015 text: 2015-November-10 day: 10 |
PublicationDecade | 2010 |
PublicationTitle | Circulation (New York, N.Y.) |
PublicationYear | 2015 |
Publisher | by the American College of Cardiology Foundation and the American Heart Association, Inc |
Publisher_xml | – name: by the American College of Cardiology Foundation and the American Heart Association, Inc |
SSID | ssj0006375 |
Score | 2.2161772 |
Snippet | IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be... Abstract only Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are... |
SourceID | crossref wolterskluwer |
SourceType | Aggregation Database Publisher |
StartPage | A13816 |
Title | Abstract 13816: Dantrolene Enhances Binding of Calmodulin to RyR2 in CPVT Which Mutation Located at Central Domain but Does Not Enhance That in CPVT With Mutation at CaM-like Domain |
URI | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-201511103-01115 |
Volume | 132 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBf9gDEYY2s31n2hh7EXoza27NjZW5ZlS6EJowljb0aW5dpksUdjM_qH7f_bnSx_hHawPuzFEUI5Ef_upztd7iRC3kWBGLqeTJh0PY-BheYs8NSQjeKR63GHS66wOHm29Bffg09Td7q335RWdX3_FWnoA6yxcvYeaLdCoQPagDk8AXV4_hPu4wiDF7K0bPyzDjf8ACxmo8OiZk3zFFHeWh-zupqlrs7aFLFOSAc_9PLm0tGVgF-_wVY_zWRqzSuTkXhRYPpUjPWPJigM_vdGwOioKqEJchdF2UxirVJRdqIw3ttKQglizn5ka2VE9J3kSXYtza1id10W1AteLDCCtqn0XUnWMs2uVJqti3YlExsBmqiDwSuxVjC2VddqXek8hi_t6LlQsTBDhRFiwiG2x3RKXqvA6LN3JTl5P_wy0Qm--mCr7sqqNk-1_cYM9K7sk-NWUir6pczndT31qTKGw3FB1euDmVrL0oVuKyztgX1FyC39afGe1Rhrjej5IF3HbQs3RAsnAYhTEA8WVgs97UnYOT18UG96fYbvCuyazp6z8VSGQweWZrAMh-PJ-cV5670Mue81tw_ibzRV9TDt2d2T7jh0j34VmOSxXesaj56ntnpCHpstFh3X3HhK9lR-RI7HuSiLzQ19T3XSs0boiDyYm9ySY_K7YQ7VE36gHW9owxtqeEOLhHa8oWVBkTcUmqjsVPOGNtpODW-oKKnhDa2VngJvKPKGAm-aSSjyphMFvOkkoQTDGyPiGVl-nq4mM2YuNWFy5Hgsko7vwroYg6svRpHwfT9IIl9FMop9xxnEMnITFzYFySCJlW2rkSN4lIggjnwe2fw5OciLXL0gNBABePcB574CD1Mmo4BLJw6SwB1wMZD2CTlrcAl_1ifXhHrHP7RDRDIEJEODZKhf7AlhO_CFdSl2-DcdennP8a_Iw46xr8lBeV2pN2R_G1dvjRb-AQy48zI |
link.rule.ids | 315,782,786,27933,27934,64549,64569,65344,65364 |
linkProvider | Ovid |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9NAEF5BKgES4tGCKM89IN_cxl7bu0bKwXUcAiRWVVsUTtY-bMVqY1eNA-oP4_8xu3GqcODAhZNH8mqs9X6ax-43Owi9F4wHni8rW3q-b4OHJjbzy8AOVej5xCWSlLo4eZrR9BsbJ_qanC1XVRefra6O9MOYaS3odjg6L8xHnzMrTc6zUWPFWTz6bp1GHxOzTa1JEtZ41P6oOitKDf2KaPML3g0CCsdQhhxdir4X-CTwBmgvmozzk1uTHRDqb1uuUYB4X0oM0dCxrK_lEaRsYMsgLCwIyEw3R9_xYg9_tvpke3VhiO077mny-D9N7Al61MevONoA7im6Uzb76CBqIHdf3mALG0ap2arfR_fm_cH9AfoVCb2nIjtsJvYBA9o0RR4sLU6ahYbeCp_UpsQGtxWO-eWyVZolj7sWn92cuRjE-PRrjs8XtVzg-XrDIcCzVnO6FOYd7neq8bhdchgt1h2IoDdtu-1HcL6Agbeq6m5Hk9bA5_ZlfVH2Kp6hbJLk8dTuO0bYMnR9W0jIsQF0CuIoHgpOKWWVoKWQQlHXHSopvMqDiKsaVqp0nDJ0OREVZ0pQIhzyHA2atilfIMw4g9CJEUJLcN-yChmRrmIVpMOED6VziI63619cba4FKUw6FTiFRkwBiCl6xBTmxx4i-w-YFJs61-JvS_ryH8e_Q_en-XxWzD6lX16hB_qtbdiKr9Ggu16Xb9DdlVq_7ZH_G-68DEE |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1bb5RAFJ5omzQmpmqrsfU2D4Y32oXhMpjwQIG1apdsCrH6ROYCWdIuNF1Wsz_M_-eZWbZZH3zwxSdOwuTAwMe5zXcYhN5zyjzHFbUpHNc1wUMTk7qVZwYycFxiE0Eq1Zx8nvvZN5qk6jc5mxV81Xy2uD1RB22mlaC2w1F5YRF-zo04j8PvRpZe5WFmTKOPqS5TK5KEMU3G4cpIwu5H3RtRpklYRBlh8HEQVliaOGSphvRduD0PPoHdaJwUZ_eG2yO-u9l4zQegDw3FEBOdiuZOnEDiBhYNgsOSgEzVFulbvuzxz06tby-uNb19y0mNn_zX6T1F-0Msi6M1-J6hB1V7gA6jFvL4-QobWLNLddn-AO1NhkX8Q_Qr4qq-Inqsp_cBA_IUXR6sLk7bmYLhAp81ut0GdzWO2c28k4oxj_sOX64ubQxiPP1a4KtZI2Z4slzzCfBFp_hdErMeD1VrnHRzBqP5sgcR9GZdv7kILmYw8F5V029pUhrYxLxprqtBxXOUj9MiPjeH3SNMEdiuyQXk2wBACTEVCzjzfZ_W3K-44NK37ZEU3KkdiL7qUS0ry6oCmxFeMyq5T7hFXqCdtmurlwhTRiGMooT4FbhyUQeUCFvSGlJjwkbCOkKnGxSUt-tfhJQ6tfKsUuGmBNyUA25K_WCPkPkHWMp1z2v5t1d6_I_j36E9QEt58Sn78go9UidNTVx8jXb6u2X1Bj1cyOXbAf6_AdFWDyM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+13816%3A+Dantrolene+Enhances+Binding+of+Calmodulin+to+RyR2+in+CPVT+Which+Mutation+Located+at+Central+Domain+but+Does+Not+Enhance+That+in+CPVT+With+Mutation+at+CaM-like+Domain&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Nishimura%2C+Shigehiko&rft.au=Yamamoto%2C+Takeshi&rft.au=Fukui%2C+Go&rft.au=Maeda%2C+Takako&rft.date=2015-11-10&rft.pub=by+the+American+College+of+Cardiology+Foundation+and+the+American+Heart+Association%2C+Inc&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=132&rft.issue=Suppl_3+Suppl+3&rft.spage=A13816&rft.epage=A13816&rft_id=info:doi/10.1161%2Fcirc.132.suppl_3.13816&rft.externalDocID=00003017-201511103-01115 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |